Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 259.428 million compared to CNY 274.337 million a year ago. Operating income was CNY 121.641 million compared to CNY 149.655 million a year ago. Net income was CNY 107.055 million compared to CNY 130.478 million a year ago. Basic earnings per share from continuing operations was CNY 0.2045 compared to CNY 0.2492 a year ago.